Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Duke Capital
FY’24 results: record cashflows
12th Jul 2024
Apax Global Alpha
CM day: further proof of value added by Apax
10th Jul 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
99: Building a medical company without a specialist background | Clare Brenner of Myogenes
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Burford Capital
Financials
Fund business shows good progress
By
Dr Brian Moretta
15 Dec 2017
genedrive Plc
Life Sciences
Remodelled for growth
By
Dr Martin Hall
13 Dec 2017
ValiRx
Life Sciences
Clinical efficacy of VAL401
13 Dec 2017
Evgen Pharma
Life Sciences
Funded to the end of Phase II trials
By
Dr Martin Hall
11 Dec 2017
Advanced Oncotherapy
Life Sciences
Distribution agreement and capital increase
By
Dr Martin Hall
11 Dec 2017
Non-Standard Finance
Financials
Loan growth, better impairments, more investment
By
Mark Thomas
07 Dec 2017
Agriculture
Jatropha Sector Review
By
Yingheng Chen
01 Dec 2017
Life Sciences
UK residential REITs: the start of a journey
By
Mike Foster
30 Nov 2017
Chamberlin Plc
Industrial
Continued technical issues lead to lower forecasts
By
Paul Singer
29 Nov 2017
Primary Health Properties
Investment Companies
Gilt edged rent collector – accelerating dividends
By
Mike Foster
23 Nov 2017
The 600 Group
Industrial
Initiation: Moving into a new growth phase
By
Paul Singer
21 Nov 2017
Prev
1
...
72
73
74
75
76
...
81
Next